Gazyva 1,000 MG/40 ML vial 40ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9EG5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,092
Award facts
- Contract value 100% obligated
- $15,092.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,092.16 to AmerisourceBergen Drug Corp for the supply of Gazyva (1,000 mg/40 ml vial) on December 4, 2025, with an ultimate completion date of December 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location in the same city. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
This delivery order represents a routine pharmaceutical supply transaction within AmerisourceBergen's broader portfolio of federal medical procurement contracts with the Defense Logistics Agency. The company serves as a critical vendor for military and veteran healthcare systems, supplying a wide range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Gazyva is a monoclonal antibody therapy used in oncology and immunology treatments, and this procurement aligns with the Defense Health Agency's pharmaceutical support needs for military healthcare programs. The contract demonstrates AmerisourceBergen's continued capability to fulfill federal medical supply requirements through open competition and its established position as a primary pharmaceutical distributor within the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F9EG5?
SPE2DR26F9EG5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F9EG5 worth?
The government has obligated $15,092 on SPE2DR26F9EG5.
Is contract SPE2DR26F9EG5 an order under another contract?
Yes. SPE2DR26F9EG5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9EG5 competed?
The extent of competition for SPE2DR26F9EG5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award